SBIR-STTR Award

Ocular fluorophotometer for use with small eyes
Award last edited on: 11/2/07

Sponsored Program
SBIR
Awarding Agency
NIH : NEI
Total Award Amount
$1,292,386
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Bruce M Ishimoto

Company Information

Ocumetrics Inc

2224 Old Middlefield Way C
Mountain View, CA 94043
   (650) 960-3955
   info@ocumetrics.com
   www.ocumetrics.com
Location: Single
Congr. District: 16
County: Santa Clara

Phase I

Contract Number: 1R43EY016902-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2005
Phase I Amount
$111,094
The purpose of this SBIR project is to develop an ocular fluorophotometer for measurement in the mouse eye. Ocular fluorophotometry has proven to be a useful and versatile technique in eye research. Small animal models of numerous ocular diseases, particularly in genetically engineered mice, present a unique opportunity. We propose to develop a system for performing ocular fluorophotometer on the mouse. Over the course of the entire project (both Phase I and Phase II), we intend to develop and test instrumentation and methods for measuring blood retinal barrier permeability, blood aqueous barrier permeability, aqueous turnover, cornea endothelial permeability and cornea epithelial permeability. During Phase I, we will limit our efforts to the measurement of aqueous turnover, but as we will explain, this will lay the foundation for the other applications and adequately answer the question of feasibility for those applications. During Phase II, we will address the other applications as well as further refine methods designed during Phase I. One area developed in Phase I that will remain a focus during Phase II will be the animal restraint system. It is our ultimate goal to develop a system that will allow rapid screening of many subjects

Phase II

Contract Number: 2R44EY016902-02
Start Date: 9/15/05    Completed: 8/31/08
Phase II year
2006
(last award dollars: 2007)
Phase II Amount
$1,181,292

The purpose of this SBIR project is to develop an ocular fluorophotometer for measurements in the mouse eye. Ocular fluorophotometry has proven to be a useful and versatile technique in eye research. Small animal models of numerous ocular diseases, particularly in genetically engineered mice, present a unique opportunity to generate a large number of disease-specific results quickly that may be applicable to human eye research. This project proposes to develop a system for performing ocular fluorophotometry on the mouse. Over the course of both Phase I and Phase II, the goal is to develop and test both instrumentation and methods for measuring tear turnover, aqueous turnover, blood retinal barrier permeability, blood aqueous barrier permeability, cornea endothelial permeability, and cornea epithelial permeability. Phase I concentrated on the measurement of aqueous turnover. All Specific Aims were successfully attained with the demonstration of highly accurate instrumentation and appropriate methodology. This lays the foundation for implementing the other applications, all of which have been successfully measured in humans with instrumentation developed by this project s manufacturer. Phase II will address these other applications as well as further refine methods designed during Phase I. In particular, an animal restraint system will be designed in which each module holding a mouse can be quickly switched in and out of the main instrument. The ultimate goal is to measure first one eye, then the other eye, and then the eyes of the next mouse, all in rapid succession and without realignment of the instrument, so that many subjects can be screened in one measurement session. The overall result of these efforts will be to produce standardized instrumentation and methodology for eye research that can be used on mice for measuring multiple ophthalmic parameters in a standardized, repeatable, and comparable manner. Project Relevance Small animal models of numerous ocular diseases, particularly in genetically engineered mice, present a unique opportunity to generate a large number of disease-specific results quickly that may be applicable to human eye research. The proposed instrument will be used in conjunction with these animal models to advance our basic understanding of human eye disease and also to rapidly screen promising drugs and other disease therapies.

Thesaurus Terms:
There Are No Thesaurus Terms On File For This Project.